Kyonggi-do, South Korea

Changwon Park


Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Changwon Park: Innovator in Immunosuppressive Agents**

Introduction

Changwon Park is a noted inventor based in Kyonggi-do, South Korea. He has made significant contributions to the field of immunology through his innovative research and patents.

Latest Patents

Changwon Park holds a patent titled "Use of rosmarinic acid and derivatives thereof as an immunosuppressant." This patent presents a groundbreaking approach wherein rosmarinic acid and its derivatives are utilized as immunosuppressive agents. The invention details how these compounds specifically inhibit the binding of ligand peptides to the Lck SH2 domain, consequently disturbing the Lck-mediated signal transduction in T cells. Furthermore, it highlights the ability of rosmarinic acid to inhibit cytokine gene expression and suppress immune responses in transplanted tissues. These findings underline the potential applicability of these compounds for treating, preventing, and diagnosing graft rejection, graft-versus-host disease (GVHD), autoimmune diseases, and various inflammatory conditions.

Career Highlights

Changwon Park is affiliated with the Mogam Biotechnology Research Institute, where he has been actively involved in research focused on immunology and related fields. His work—especially the patented use of rosmarinic acid—represents a significant advancement in therapies aimed at modulation of immune responses.

Collaborations

Throughout his career, Changwon Park has collaborated with esteemed colleagues, including Eun Mi Hur and Young Bong Choi. These partnerships have enhanced his research endeavors and contributed to the successful development of innovative solutions within the realm of biotechnology.

Conclusion

In summary, Changwon Park is a distinguished inventor whose work with rosmarinic acid and its derivatives has paved the way for potential advancements in immunosuppressive therapies. His contributions, rooted in innovative research, are critical in addressing significant medical challenges associated with immune responses.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…